Presentation to Include Additional Positive Data from the Recently Completed PRIME Clinical Study - SAN DIEGO, CA / ACCESS Newswire / January 14, 2026 / Revelation Biosciences Inc. (NASDAQ:REVB) (the ...
Quarterly Filing a Day Earlier Than Previously Stated to be Followed by CEO Interview and Investor Q&A at 4:05 PM ET Detroit, ...
AEye, Inc. (Nasdaq: LIDR), a global leader in software-defined, high-performance lidar solutions, today announced a strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback